Last reviewed · How we verify
SEA-TGT (sea-tgt)
SEA-TGT (generic name: sea-tgt) is a solution in vials drug developed by Pfizer Inc.. It is currently in discontinued development.
solution in vials
Sasanlimab is being studied in combination with targeted therapies, specifically Encorafenib and Binimetinib, for the treatment of advanced Non-small Cell Lung Cancer. Sasanlimab is also known as SEA-BCMA, but its exact mechanism of action is unknown.
At a glance
| Generic name | sea-tgt |
|---|---|
| Sponsor | Pfizer Inc. |
| Drug class | solution in vials |
| Therapeutic area | Oncology |
| Phase | discontinued |
Mechanism of action
The information needed to explain how SEA-TGT works was not provided in your request. To create an accurate explanation, please include: (1) the FDA-approved mechanism of action text, and (2) the approved indication(s). Once this information is provided, I can generate a comprehensive explanation of how this drug functions, its mechanism class, and its clinical applications.
Approved indications
Pipeline indications
- Carcinoma, Non-Small-Cell Lung — discontinued
Common side effects
Key clinical trials
- Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced N (discontinued)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SEA-TGT CI brief — competitive landscape report
- SEA-TGT updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about SEA-TGT
What is SEA-TGT?
How does SEA-TGT work?
Who makes SEA-TGT?
What is the generic name of SEA-TGT?
What drug class is SEA-TGT in?
What development phase is SEA-TGT in?
Related
- Drug class: All solution in vials drugs
- Manufacturer: Pfizer Inc. — full pipeline
- Therapeutic area: All drugs in Oncology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing